Evidence map›Paper›PMID 36601401›Full record

ArticleFrontiers in microbiology2022

Allison Campolo, Reed Pifer, Rhonda Walters, Megan Thomas, Elise Miller, Valerie Harris, Jamie King, Christopher A Rice, Paul Shannon, Brian Patterson and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Pathogens (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in ophthalmology · 2025
    Article
  8. Review
  9. Article
  10. New Frontiers inBiology · 2023
    Review
  11. Complete Recovery ofMicroorganisms · 2023
    Article
  12. Biological characteristics and pathogenicity ofFrontiers in microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Allison CampoloAlcon Research, LLC, Fort Worth, TX, United States.
Reed PiferAlcon Research, LLC, Fort Worth, TX, United States.
Rhonda WaltersAlcon Research, LLC, Fort Worth, TX, United States.
Megan ThomasAlcon Research, LLC, Fort Worth, TX, United States.
Elise MillerAlcon Research, LLC, Fort Worth, TX, United States.
Valerie HarrisAlcon Research, LLC, Fort Worth, TX, United States.
Jamie KingAlcon Research, LLC, Fort Worth, TX, United States.
Christopher A RiceDepartment of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN, United States.
Paul ShannonAlcon Research, LLC, Fort Worth, TX, United States.
Brian PattersonAlcon Research, LLC, Fort Worth, TX, United States.
Monica CraryAlcon Research, LLC, Fort Worth, TX, United States.
Alcon (United States) · USPurdue University West Lafayette · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: Six clinically and/or scientifically relevant strains of Results: Discussion: Aggregation/encystment is a protective mechanism which may enable

Indexed as

Acanthamoebaaggregatecontact lenscontact lens solutioncystspheroid

Identifiers

PMID36601401
PMCPMC9806144
OpenAlexW4313389725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.